SCHEMBL8336995

SCHEMBL8336995

COc1ccc([N+](=O)[O-])cc1NC(=S)NC(C(=O)Nc1ccc2c(c1)CCC2)c1ccsc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 11/20 0.47
KMT2A Q03164 11/20 0.47
MAPT P10636 5/20 0.47
POLB P06746 3/20 0.47
HTT P42858 2/20 0.47
MAPK1 P28482 2/20 0.47
BLM P54132 1/20 0.47
ALDH1A1 P00352 7/20 0.46
LMNA P02545 6/20 0.46
SMN1; SMN2 Q16637 4/20 0.46
CASP3 P42574 1/20 0.45
SENP7 Q9BQF6 1/20 0.45
NPC1 O15118 2/20 0.42
RAB9A P51151 2/20 0.42
KDM4E B2RXH2 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2D6 P10635 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8335661 0.93 MEN1 (0.52) MEN1KMT2AMAPTPOLBHTT
SCHEMBL6718750 0.89 MEN1 (0.57) MEN1KMT2AMAPTPOLBHTT
SCHEMBL8334628 0.87 MEN1 (0.49) MEN1KMT2AMAPTPOLBHTT
SCHEMBL6726583 0.86 HTT (0.51) MEN1KMT2AMAPTPOLBHTT
SCHEMBL6723227 0.82 MEN1 (0.53) MEN1KMT2AMAPTPOLBHTT
SCHEMBL6718289 0.81 MEN1 (0.56) MEN1KMT2AMAPTPOLBHTT
SCHEMBL6719479 0.81 MEN1 (0.56) MEN1KMT2AMAPTPOLBHTT
SCHEMBL6715985 0.81 MEN1 (0.51) MEN1KMT2AMAPTPOLBHTT
SCHEMBL8328544 0.80 MEN1 (0.54) MEN1KMT2AMAPTPOLBHTT
SCHEMBL6718768 0.78 KMT2A (0.51) MEN1KMT2AMAPTPOLBHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004022528-A2 ARYLGLYCINE DERIVATIVES AND THEIR USE AS GLYCINE TRANSPORT INHIBITORS NPS ALLELIX CORP. (CA) 2004-03-18 WO disclosed